Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Myriad Uranium Re-Assumes 100% Control of High-Grade Breccia Pipes Near Pinyon Plain Mine, Terminates Wedgemount Option
-
metaphactory by Digital Science Now Available on SAP Store
-
Watson Farley & Williams Goes Fully Mobile with SwiftConnect for Employee Access at New London HQ
-
GMV Minerals Announces Assays from 2026 Diamond Drill Program including: 12.64 gpt Gold over 4.88 m in MHC26-14
-
Scalefusion Introduces Veltar Vulnerability Management to Connect Vulnerability Detection and Remediation
-
Global Product Placement Spending Grew 12.7% in 2025 to $37.2B & Pacing for Faster Growth Again in 2026, Driven by TV, Film, Music & Digital Media
-
VSI® Expands Surgical Capabilities to Meet Growing Patient Demand, Welcomes Spine Surgeon Dr. Alexander Upfill-Brown
-
MintNeuro raises $5 million to scale purpose-built chip platform for neural devices and brain-computer interfaces
-
MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class Muscle Regeneration Therapy in Stress Urinary Incontinence
-
Organizational AI use grows eightfold, yet governance gap remains: survey
-
Fortuna reports third quarter 2026 production of 69,665 gold equivalent ounces and advances key growth initiatives
-
Clear Street Partners with Seawolf Capital to Bring Strategic Markets Content and Events to the Investing Community
-
ITM and Lumara Bio to Announce New Data for ¹⁷⁷Lu-edotreotide (ITM-11) and Ga-DPI-4452 at EANM 2026
-
MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class Muscle Regeneration Therapy in Stress Urinary Incontinence
-
KT&G Begins Full-Scale Operations at New Indonesia Plant, Completing Five-Country Global Production System
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PHAROS ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary Shares
-
ITDock Expands MSP Documentation Platform With Self-Hosted Deployment and New Technician Workflow Tools
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Dubai attracts 14,600 applications for 23 places on global talent programme
-
S&K Roofing Launches Instant Online Roofing Estimates for Northeast Ohio Homeowners
-
South Padre Island Vacation Rental Report 2027: Rising Lodging Revenue, Regional Investment and Road-Trip Value Point to Continued Demand
-
Result of the auction of 2.00 per cent DGB 2028 and 2.25 per cent DGB 2035
-
San Francisco Speeding Ticket Attorney Adam Cohen Explains Fines, DMV Points, and Defense Options for California Drivers
-
Chicago Divorce Attorney Michael Ian Bender Highlights Privacy Strategies for High-Profile Divorce
-
Hudson Valley DWI Defense Attorney Randall F. Inniss Guides Physicians Through Medical License Protection After a DWI Arrest
-
Ocean County Estate Planning Attorney Christine Matus Outlines Essential Estate Planning Tools for New Jersey Families
-
Boston Truck Accident Attorney Dino M. Colucci Outlines Liability and Federal Regulations in 18-Wheeler Collisions
-
TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM's incentive program
-
EGFR Non Small Cell Lung Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Astrazeneca, Bridge Biotherapeutics, Sichuan Kelun Pharma
-
Diabetic Foot Ulcers Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience
-
Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Tech
-
Deutsche Lufthansa AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
-
Inflammatory Bowel Disease Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly, Gilead
-
Degenerative Disc Disease Pipeline 2026: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutics, BIOPHARM
-
Chronic Smell and Flavor Loss Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Cyrano Therapeutics
-
Neuroblastoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Y-mAbs Therapeutics, United Therapeutics Corp, EUSA Pharma, Clarity Pharma
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 06 10 2026] - (CGWL)
-
Krait Critical Minerals Appoints Dr. Thomas O'Rourke as Strategic Advisor
-
Liver Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
-
Focal Segmental Glomerulosclerosis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Retrophin, AbbVie, AstraZeneca, Pfizer, Sanofi, Teva
-
Alpha Thalassemia Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Forma Therapeutics, Genmedicon Biopharma, Bristol-Myers Squibb, Agios Pharma
-
Cerebral Palsy Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Neurocrine Biosciences, Teva Pharma, Bundang CHA Hospital, Jazz Pharma
-
Beyond Now launches agentic platform to power CSPs growth in the agentic economy
-
Gemcorp and Fonds Souverain Malagasy Announce Strategic Partnership to Support Investment in Madagascar
-
Real machining challenges take centre stage for Dormer Pramet at AMB 2026
